-
www.ahrq.gov/policymakers/chipra/demoeval/demostates/nc.html
March 01, 2019 - the State's medical home model improve quality of care for children with behavioral and developmental disorders
-
hcup-us.ahrq.gov/news/exhibit_booth/neds_brochure.jsp
May 01, 2018 - large sample size, which allows for analysis across hospital types and the study of relatively uncommon disorders
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan-aspirin-to-prevent-cardiovascular-diseas/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
October 07, 2013 - with atrial fibrillation; patients with familial hypercholesterolemia; patients with hypercoagulable disorders
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/2024_Intervention_Content_Statin_Patient_1.xlsx
January 01, 2024 - Preventive Medication
Resource Name & location Description Format URL or PDF name
JAMA Patient Page: Lipid Disorders
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra_1415-p011-1-ef_0.pdf
March 01, 2015 - most expensive, highest in risk, and fastest growing of therapeutic
classes for children with mental disorders
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-3-nonopioid-pharmacol-chronic-pain.xlsx
May 29, 2025 - 10.91
Baseline function/disability, RMDQ (0-24): 11.43
Psychiatric comorbidity: NR, but excluded many disorders
-
www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/reports-congress/fourteenth-annual-report-congress-high-priority-evidence-gaps-across-lifespan-all-communities
November 01, 2024 - nationwide: Prevention of Child Maltreatment: Primary Care Interventions Speech and Language Delay and Disorders
-
www.ahrq.gov/patient-safety/settings/long-term-care/resource/hcbs/report/apv3ab.html
June 01, 2010 - of Mental Health, Mental Retardation, and Substance Abuse Services
Children with psychiatric disorders
-
www.ahrq.gov/nursing-home/nursing-home-network.html
November 01, 2021 - Number of Sessions
Advocate Aurora Health
60
2
33
Alzheimer's Disease and Related Disorders
-
www.ahrq.gov/ncepcr/reports/2025-annual-report/appendixc.html
August 01, 2025 - After Pregnancy: A Systematic Review and Meta-Analysis; and (2) Management of Postpartum Hypertensive Disorders
-
www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/mui/ui-referral-list.docx
June 02, 2025 - · Urogynecology: You can use the Voices for Pelvic Floor Disorders (www.voicesforpfd.org) website:
-
effectivehealthcare.ahrq.gov/products/chronic-cough/research-protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pelvic-pain_executive.pdf
January 01, 2012 - Prevalence of pelvic
musculoskeletal disorders in a female chronic pelvic
pain clinic.
-
hcup-us.ahrq.gov/reports/ataglance/HCUPAnalysisCA2018Wildfires.pdf
November 07, 2019 - J703 Chronic drug-induced interstitial lung disorders
J704 Drug-induced interstitial lung disorders … J9819 Other pulmonary collapse
J982 Interstitial emphysema
J983 Compensatory emphysema
J984 Other disorders … classified
J9851 Mediastinitis
J9859 Other diseases of mediastinum, not elsewhere classified
J986 Disorders … of diaphragm
J988 Other specified respiratory disorders
J989 Respiratory disorder, unspecified
J99 … Respiratory disorders in diseases classified elsewhere
M0510 Rheumatoid lung disease with rheumatoid
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary51/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication-september-2014
April 08, 2014 - Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. … Migraine is a risk factor for hypertensive disorders in pregnancy: a prospective cohort study. … Migraine-asthma comorbidity and risk of hypertensive disorders of pregnancy. … Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach. … Psychosocial impact of early-onset hypertensive disorders and related complications in pregnancy.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/9Ks34K-BnsDSBK4MYDATYS
August 09, 2016 - Childhood dyslipidemia is typically multifacto-
rial, with the exception of lipid disorders of genetic … reviews to support the USPSTF in up-
dating its 2007 recommendation statement on screening for lipid
disorders … tions were excluded from this review, as were renal, infectious,
hepatic, inflammatory, and storage disorders … Screening and treatment
for lipid disorders in children and adolescents:
systematic evidence review for … Screening
for lipid disorders in children: US Preventive
Services Task Force recommendation statement
-
effectivehealthcare.ahrq.gov/products/mental-health-children/research-protocol
-
www.ahrq.gov/sites/default/files/wysiwyg/ncepcr/reports/2024-annual-report/ncepcr-grant-summaries-table.pdf
January 01, 2024 - ©) model to train primary
care providers in rural New Mexico to provide medications for opioid use disorders
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/meditation_research-protocol.pdf
October 17, 2012 - Clinician reports of substance
abuse, sleep and eating disorders
1. … Mindfulness based cognitive therapy for psychiatric disorders: A systematic
review and meta-analysis … Meditation therapy for
anxiety disorders. Cochrane Database Syst Rev. 2006(1):CD004998.
12. … Mindfulness meditation for
substance use disorders: a systematic review. Subst Abus. … A review of empirically supported psychological therapies for mood disorders
in adults.
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/obesity-in-adults-screening-and-counseling-2003
December 15, 2003 - Risk was strongest for cardiovascular disorders. 37 , 43 , 47 Breast, colon, uterine, and ovarian cancer … Disorders associated with clinically severe obesity: significant improvement after surgical weight reduction … good quality)
- Outcome: weight loss or BMI reduction; glucose tolerance, blood pressure, lipid disorders … good quality)
- Outcome: weight loss or BMI reduction; glucose tolerance, blood pressure, lipid disorders … good quality)
- Outcome: weight loss or BMI reduction; glucose tolerance, blood pressure, lipid disorders